Sample Collection From Melanoma Patients
The goal of this laboratory research study is to collect blood and tumor samples from patients with malignant melanoma. Researchers want to store these samples in a secure and confidential laboratory at M. D. Anderson. Researchers will use the information that is learned in this study to help find ways to improve treatment for melanoma and other cancers.
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Blood and Tumor Sample Collection From Patients With Malignant Melanoma for Long Term Storage|
- Collection and long-term collection of blood and tumor samples from patients with malignant melanoma for future biological and/or surrogate marker studies. [ Time Frame: 6 Years ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
Patients will provide blood and tumor samples to help researchers learn about melanoma and other cancers.
|Study Start Date:||June 2006|
|Estimated Primary Completion Date:||June 2017 (Final data collection date for primary outcome measure)|
Blood Sample + Tumor Sample
Blood samples will be collected. Tumor samples will be collected using a small needle, a punch knife, or a small surgery.
Procedure: Blood Sample
Blood samples will be collected.Procedure: Tumor Sample
Tumor samples will be collected using a small needle, a punch knife, or a small surgery.
Show Detailed Description
Please refer to this study by its ClinicalTrials.gov identifier: NCT00507325
|United States, Texas|
|University of Texas MD Anderson Cancer Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Kevin B. Kim, MD||M.D. Anderson Cancer Center|